Prepare your cardiology practice for sale by running a 36-month readiness program that covers financial hygiene, physician compensation restructuring, imaging and ambulatory revenue capture, MSO or PE buyer alignment, Stark and Anti-Kickback compliance, and physician retention. Owner cardiologists who stage this sequence typically expand the enterprise-value multiple band from a 7x to 9x floor to a 10x to 14x adjusted EBITDA range at close, while cutting the diligence-to-close timeline from 9-12 months down to 5-7 months.

This playbook lays out what to do at T minus 36 months, T minus 24, T minus 12, and T minus 6, why cardiology-specific buyers pay premiums for particular attributes, and where practices consistently leak value in diligence. It sits alongside our companion Cardiology PE Roll-Up Tracker (buyer intelligence) and How to Sell a Cardiology Practice (transaction mechanics). For the parent framework, see the Prepare Your Business for Sale hub.

Why 36 months is the right runway to prepare a cardiology practice for sale

Thirty-six months is the runway needed to normalize three trailing years of financials, restructure physician compensation without triggering churn, complete the ambulatory revenue capture cycle, and demonstrate two full audit years of clean coding and denial rates to a strategic or private equity buyer. Compressed timelines (under 18 months) may still produce a transaction, but often at a 2 to 4 turn EBITDA discount because trailing-twelve-month adjustments have to be justified from a shorter data window.

The Medical Group Management Association (MGMA) reports that specialty practices completing at least 24 months of pre-transaction preparation close at meaningfully higher multiples than those going to market cold, and cardiology specifically shows one of the largest prep-versus-cold spreads because of the imaging and ambulatory-surgical-center revenue lines that require 12 to 18 months to fully migrate onto the practice P&L. (Sources: MGMA DataDive, ACC Practice Management resources.)

The 36-month sequenced timeline

Step 1: Financial hygiene that survives quality-of-earnings diligence

Financial hygiene means producing three trailing years of GAAP-consistent P&L, balance sheet, and cash-flow statements segmented by payer, site of service, and physician, with a defensible add-backs schedule and a documented working-capital normalization. Cardiology is diligence-heavy because commercial payer mix, imaging technical fees, and physician productivity all interact with EBITDA in ways a generic QoE provider will misclassify.

Payer mix reporting

Buyers price cardiology practices largely off commercial payer concentration and Medicare Advantage exposure. Report your payer mix as a percentage of net collections (not gross charges), broken down by top 10 payers, and show 36-month trend. Practices that can demonstrate commercial concentration above 45% of net collections and Medicare Advantage above 20% typically fetch premium multiples. See CMS statistical supplement for national benchmarks.

Denials cleanup

Best-in-class cardiology practices run denial rates below 5% of billed charges and initial-pass yield above 95%, per HFMA benchmarks (Healthcare Financial Management Association). If your practice sits above 8%, that gap is a $200,000 to $1,200,000 EBITDA leak that gets modeled as either a run-rate adjustment or a purchase-price haircut. Start the cleanup at T-24, so you have two clean audit years by close.

Add-backs and physician compensation normalizations

Cardiology QoE reports routinely surface add-backs in these categories: owner-physician above-market compensation, personal auto and travel, family payroll, non-recurring litigation, real estate rent above fair market value, and one-time practice management system migrations. Every add-back needs contemporaneous documentation. For the buyer-side view of what typically gets accepted, see our sell-side QoE deep dive.

Step 2: Restructure physician compensation before you go to market

Restructuring physician compensation means moving owner cardiologists from a “residual owner-take” model to a market-based W-2 salary plus productivity bonus, generally at the 50th to 75th percentile of MGMA cardiology compensation benchmarks. The delta between historical owner take and market-based comp becomes the largest single EBITDA add-back in most cardiology deals, so it may materially expand the sale price if documented before closing.

The MGMA 2025 Provider Compensation Report cites median total compensation for non-invasive cardiology at approximately $580,000, invasive at $680,000, and interventional/EP at $720,000 to $820,000 (MGMA Data Stories). Buyers typically require retained owner physicians to sign five-year employment agreements at these market bands, with rollover equity making up 20% to 40% of headline enterprise value.

Timing sequence for compensation restructuring

1. T-30 months: model current owner take versus MGMA percentiles; identify the total add-back opportunity.
2. T-24 months: implement W-2 comp at market for all owner physicians; run 12 months of clean payroll.
3. T-12 months: document the restructured comp in board minutes and employment agreements to satisfy QoE scrutiny.
4. T-6 months: negotiate go-forward employment terms and rollover equity with the eventual buyer.

Step 3: Operational readiness, ambulatory shift, and imaging revenue capture

Operational readiness in cardiology means documenting standardized clinical protocols, migrating appropriate procedures to office-based labs and ambulatory surgical centers, and capturing the technical component of imaging on the practice P&L rather than leaving it with a hospital or joint venture partner. This workstream may add 3 to 8 turns of adjusted EBITDA over a 24-month execution window.

Ambulatory shift: the site-of-service tailwind

CMS site-neutral payment policy has continued to shift procedures out of hospital outpatient departments (HOPDs) toward office-based labs and ambulatory surgical centers. The Advanced Cardiovascular Center of Excellence code set (including diagnostic cath, PCI in appropriate cases, and select structural heart pre-procedures) has migrated meaningfully. Practices that own or joint-venture ASCs and OBLs capture facility fees at 60% to 80% of hospital rates, at meaningfully higher margin. (CMS ASC Payment System.)

Imaging revenue capture

Cardiac imaging (echocardiography, nuclear cardiology, cardiac MRI, coronary CT angiography) generates a technical component fee under Medicare Physician Fee Schedule when performed in an office setting. Practices that own the equipment and bill the technical component capture 100% of MPFS rates, per the CMS Medicare Physician Fee Schedule. Under the arrangement where imaging is referred out, the practice captures only the professional component.

For a mid-sized cardiology group ($20M revenue, 10 physicians), moving 60% of imaging in-house often adds $2M to $4M of annual EBITDA within 18 months, which at 10x translates to $20M to $40M of enterprise value at exit.

Standardized clinical protocols

Buyers pay a premium for practices where clinical care is driven by written protocols rather than individual physician preference. Protocols reduce variability, support quality reporting under the CMS Merit-based Incentive Payment System (MIPS), and de-risk the post-close operating model. American College of Cardiology (ACC Guidelines) and American Heart Association (AHA Guidelines and Statements) provide the reference frameworks most MSO buyers expect.

Step 4: Understand the MSO and PE buyer landscape before you pick an advisor

The cardiology MSO and PE buyer landscape consolidated meaningfully between 2020 and 2026, with five to seven active national platforms and roughly 25 to 30 regional strategics. Owners preparing for sale should map likely acquirers 18 to 24 months out, because platform fit (geography, service line mix, EMR system, physician culture) can move the multiple by 2 to 3 turns independent of financial performance.

Active national cardiology MSO/PE platforms (representative)

Individual platform names, sponsors, and structures may change through further consolidation. Cross-check against the Cardiology PE Roll-Up Tracker, which we refresh quarterly, and see broader context in our M&A Advisory hub.

Strategic (health-system) buyers

Hospital-owned physician arrangements remain a viable exit channel, particularly in markets where a dominant health system is defending referral flow against MSO consolidation. Strategic buyers may pay comparable multiples on adjusted EBITDA but often structure differently: less cash at close, longer physician employment guarantees, and health system fair-market-value review under Stark. See MedPAC on hospital-physician alignment (MedPAC Reports to Congress).

Step 5: Exit multiple targets by practice tier

Cardiology multiples in 2026 range from roughly 7x to 14x adjusted EBITDA for whole-practice transactions, with tier placement driven by four attributes: physician count, imaging density, ambulatory percent of revenue, and payer diversification. The following grid reflects observed transaction ranges based on published deal reports and CT Acquisitions engagement data; individual outcomes vary with market, buyer competition, and structure.

Cardiology multiple-tier grid

Sources: management estimates informed by public transaction disclosures compiled by PitchBook, Baker Tilly Healthcare M&A, and industry publications including Becker’s Payer Issues. See also the American Hospital Association data insights and HIMSS for underlying operational benchmarks.

What moves you up a tier

• Adding a second imaging modality (for example, adding cardiac CT to an echo-only practice) may add 1 turn.
• Bringing an ASC or OBL onto the practice books at meaningful volume may add 1 to 2 turns.
• Diversifying payer mix so no single payer exceeds 30% may add 0.5 to 1 turn.
• Adding two to four employed physicians on multi-year contracts may move a Tier 3 practice into Tier 2 territory.

Step 6: Regulatory grid, Stark, Anti-Kickback, and the 2026 CMS TEAM model

Regulatory posture is where late-stage cardiology deals collapse or repricing. Owners preparing for sale should confirm alignment with the Stark Law Group Practice definition, refresh Anti-Kickback Statute compliance for any medical directorships or joint ventures, and model the impact of the CMS Transforming Episode Accountability Model (TEAM) that becomes mandatory January 2026 for participating hospitals.

Stark Law Group Practice safe harbor

The Stark Law “in-office ancillary services” exception requires the practice to qualify as a Group Practice, which imposes specific requirements on unified business structure, distribution of expenses and income, physician-services provision, and compensation. Non-compliance may disqualify designated health services (DHS) revenue, and imaging is DHS. Refer to CMS physician self-referral regulations.

Anti-Kickback Statute (AKS)

Any medical director, joint venture, or hospital arrangement where remuneration is exchanged for referrals may implicate AKS. Cardiology practices with hospital co-management agreements or device-company consulting arrangements should refresh fair-market-value documentation, ideally with a third-party valuation from a firm like Health Capital Consultants or VMG Health. See OIG Compliance Guidance and the OIG Advisory Opinions catalog.

CMS TEAM mandatory bundled payment model (2026)

CMS finalized the Transforming Episode Accountability Model (TEAM) in the FY 2025 IPPS rule, with mandatory participation for select hospitals starting January 1, 2026, covering five surgical episodes including coronary artery bypass graft (CABG). Cardiology practices that refer to or receive referrals from TEAM-participating hospitals may need to update referral arrangements and shared-savings frameworks. See the CMS TEAM Model page.

Corporate Practice of Medicine (CPOM)

State CPOM doctrines vary meaningfully. Texas, California, New York, and Illinois enforce CPOM in ways that require the MSO structure (professional entity owned by licensed physicians, with a management services organization providing non-clinical services). Other states (Florida, Arizona) apply CPOM more permissively. A buyer will diligence state-specific structure, so owner physicians should validate their PC / PLLC structure with health-regulatory counsel at T-24 months. See the AMA overview on Corporate Practice of Medicine.

Step 7: Retain key personnel and plan owner-physician succession

Buyers underwrite cardiology deals largely on the assumption that retained physicians will produce at close-year run-rate for at least three to five years. Owners preparing for sale should document key personnel dependencies, secure non-owner physician contracts with three-plus-year terms and non-competes where enforceable, and design owner-physician succession that aligns with the buyer’s exit horizon.

Owner-physician succession

Most PE-backed cardiology transactions require owner physicians to sign five-year go-forward employment agreements with 20% to 40% equity rollover. Owners within three years of retirement should model the tradeoff between accepting a lower rollover percentage (for a shorter go-forward commitment) or negotiating a “founding physician” transition role at reduced clinical load in years three through five.

Key personnel retention

1. Identify top three non-owner physicians by wRVU production; secure three-year employment agreements.
2. Retain practice administrator, revenue cycle leader, and clinical operations leader with stay bonuses payable at close-plus-12 and close-plus-24.
3. Document standard operating procedures so the practice does not depend on tacit knowledge held by one or two individuals.

Non-compete enforceability

Following the September 2024 federal district court decision vacating the FTC’s proposed nationwide non-compete ban (Ryan LLC v. FTC) and subsequent appellate proceedings, physician non-compete enforceability continues to be governed at the state level. States including California, Minnesota, North Dakota, and Oklahoma limit or bar physician non-competes; states including Florida, Texas, and Georgia continue to enforce reasonable non-competes with duration and geography limits. See AMA non-compete guidance.

Step 8: Tail insurance, malpractice, and pre-close risk transfer

Tail insurance (“nose” or extended reporting endorsement) is a discrete pre-close cost that owners routinely underestimate and buyers routinely require. For claims-made professional liability policies, the tail may cost 150% to 300% of the annual premium and must be procured for each retiring physician who will not continue coverage under the buyer’s policy.

Cardiology tail costs commonly range from $30,000 to $120,000 per retiring physician depending on state, subspecialty, and prior claims history. Owners should get an indicative tail quote at T-12 months so the number is priced into net proceeds, not surfaced as a diligence adjustment. Interested owners can benchmark through The Doctors Company and MedPro Group.

Step 9: Running the process, T minus 6 months to close

The last six months are the transaction sprint: assembling the confidential information memorandum, populating a virtual data room, running buyer outreach, negotiating letters of intent, and executing definitive agreements. Owner physicians who have completed steps 1 through 8 typically close in five to seven months from CIM launch; owners who skipped preparation stages may see 9 to 14 months and a lower net multiple.

The 6-month transaction sprint

1. T-6 to T-5: Engage sell-side M&A advisor; kick off sell-side quality of earnings.
2. T-5 to T-4: Complete CIM, financial model, and data room; assemble management presentation.
3. T-4 to T-3: Buyer outreach; first-round indications of interest; management meetings.
4. T-3 to T-2: Second-round bids; select finalist; negotiate letter of intent. See our seller-side LOI template.
5. T-2 to T-1: Confirmatory diligence, definitive agreement drafting, regulatory notifications.
6. T-1 to close: Signing, HSR clearance if applicable, funding, and closing.

HSR notification thresholds

The 2026 Hart-Scott-Rodino Act size-of-transaction threshold sits at approximately $126.4 million (adjusted annually by the FTC). Most single-practice cardiology transactions fall below the reporting threshold; platform-level rollups that acquire multiple groups in short succession may aggregate. Verify current thresholds at the FTC Premerger Notification Program.

Common mistakes that leak value in cardiology exits

• Waiting until T-6 to restructure owner compensation, leaving buyers to model add-backs off a single normalized month.
• Leaving imaging technical fees at a hospital joint venture rather than moving them onto the practice P&L 18 months pre-sale.
• Failing to procure tail-insurance quotes early, which creates a last-minute purchase-price adjustment.
• Signing a letter of intent with a single buyer without competitive process, giving up 1 to 3 turns of multiple.
• Not documenting standardized clinical protocols, forcing the buyer to underwrite key-physician dependency risk.
• Ignoring Stark Group Practice compliance until diligence, which can force late-stage repricing on DHS revenue.

Frequently asked questions

How much is a cardiology practice worth?

Cardiology practices in 2026 generally transact at 7x to 14x adjusted EBITDA, depending on size, imaging density, ambulatory percentage, and payer diversification. A single-physician group with $500,000 EBITDA may see 5x to 7x, while a 15-physician platform with $10M adjusted EBITDA, imaging vertical, and diversified commercial payer mix may see 12x to 14x. Enterprise value depends more on scarcity of platform-quality assets than on trailing revenue.

What is the EBITDA multiple for a cardiology practice?

Adjusted EBITDA multiples for cardiology in 2026 sit in a 7x to 14x range across the market. Tier 1 platforms with over $8M adjusted EBITDA, 15-plus physicians, and imaging-heavy revenue mix regularly see 11x to 14x. Tier 3 bolt-ons in the $1M to $3M EBITDA range typically see 7x to 9x. Multiples reflect adjusted EBITDA (post-comp normalization), not reported EBITDA.

How long does it take to sell a cardiology practice?

A well-prepared cardiology practice with completed sell-side quality of earnings, clean data room, and pre-briefed physician group typically runs 5 to 7 months from CIM launch to close. Practices that go to market without prior preparation may take 9 to 14 months and often accept a 1 to 3 turn EBITDA discount from the initial indication of interest to final consideration.

Do private equity firms buy cardiology practices?

Yes. As of 2026, at least five to seven national PE-backed cardiology MSO platforms (including US Heart & Vascular, CVAUSA, Cardiovascular Logistics, and others) are active buyers, along with 25 to 30 regional strategic and MSO buyers. See our Cardiology PE Roll-Up Tracker for current buyer inventory and recent transaction activity.

Should I sell to a hospital or an MSO?

Hospital and MSO buyers offer materially different tradeoffs. Hospitals may guarantee physician employment for longer but often pay lower headline multiples on adjusted EBITDA and impose Stark fair-market-value review. MSOs typically pay higher multiples with rollover equity and shorter go-forward employment guarantees. The right answer depends on physician age profile, retirement plans, and appetite for a second liquidity event in five to seven years.

What is the CMS TEAM model, and how does it affect cardiology practice sales?

The CMS Transforming Episode Accountability Model (TEAM) is a mandatory bundled-payment program starting January 1, 2026 for select acute-care hospitals, covering five surgical episodes including CABG. Cardiology practices that refer to or share risk with TEAM hospitals should document their referral and gainsharing arrangements before diligence, because a buyer will underwrite regulatory posture around bundled-payment participation.

Do I need a specialist M&A advisor for a cardiology practice sale?

Cardiology exits involve specialty-specific dynamics (imaging capture, MSO buyer landscape, Stark and AKS interaction, physician compensation restructuring) that a generalist M&A advisor may under-price. A healthcare-specialty sell-side advisor typically pays for their fee 3 to 5 times over through improved buyer competition and structured negotiation. Learn more at our M&A Advisory hub.

For general practitioners of exit planning across specialties, related playbooks include Medical Spa Exit and Home Health Exit.

Additional primary-source references

• CMS Physician Self-Referral (Stark) regulations
• HHS OIG Compliance Guidance
• CMS TEAM Model overview
• American College of Cardiology practice management
• American Heart Association guidelines
• MGMA DataDive benchmarks
• HFMA revenue cycle management resources
• MedPAC Reports to Congress
• CMS Medicare Physician Fee Schedule
• CMS ASC Payment System
• FTC HSR Premerger Notification Program
• AMA Corporate Practice of Medicine
• AMA physician non-compete guidance
• PitchBook healthcare M&A reports
• Baker Tilly healthcare M&A insights
• Becker’s Payer and ASC coverage
• American Hospital Association data insights
• HIMSS resources
• CMS Medicare Medicaid statistical supplement
• The Doctors Company (tail insurance)
• MedPro Group (tail insurance)